日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

DeepECC: a deep learning framework for genome-wide identification and analysis of human cancer eccDNAs

DeepECC：一种用于全基因组识别和分析人类癌症环状DNA的深度学习框架

期刊:Nucleic Acids Research
影响因子:13.1
doi:10.1093/nar/gkag198
Wang, Changcheng; Xu, Yisen; Li, Rufeng; Qiang, Min; Guo, Chen; He, Qian; Wu, Xiaokang; Hou, Lingmi; Xu, Qiuran; Xu, Yungang
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

RST2G: Residual-Guided Spatiotemporal Transformer Graph Fusion Enhancement for Breast Cancer Segmentation in DCE-MRI

RST2G：基于残差引导的时空Transformer图融合增强算法在动态对比增强磁共振成像（DCE-MRI）乳腺癌分割中的应用

期刊:Cyborg and Bionic Systems
影响因子:2
doi:10.34133/cbsystems.0502
Xie, Shaoli; Xu, Lulu; Lei, Chenyi; Wang, Jinxiang; Wang, Jason; Wang, Zhibin; Sun, Yiran; Li, Danyi; Li, Fangfang; Lin, Rubing; Yang, Hongwei; Xiao, Yang; Lv, Tianxu; Huang, Yixuan; Hou, Lingmi; Li, Junyan; Chen, Maoshan
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

A select inhibitor of MORC2 encapsulated by chimeric membranecoated DNA nanocage target alleviation TNBC progression

一种选择性MORC2抑制剂，被包裹在嵌合膜包覆的DNA纳米笼中，可靶向缓解三阴性乳腺癌的进展。

期刊:Materials Today Bio
影响因子:10.2
doi:10.1016/j.mtbio.2025.101497
Su, Xiaohan; Luo, Yunbo; Wang, Yali; Qu, Peng; Liu, Jun; Han, Shiqi; Ma, Cui; Deng, Shishan; Liang, Qi; Qi, Xiaowei; Cheng, Panke; Hou, Lingmi
肿瘤
肿瘤免疫
乳腺癌
ORC2
MORC2
发表日期：2025
文献求助 收藏

A selective RCC1 inhibitor loaded in membrane-coated DNA nanocage for targeted suppression of TNBC progression

一种负载于膜包覆DNA纳米笼中的选择性RCC1抑制剂，用于靶向抑制TNBC进展。

期刊:Materials Today Bio
影响因子:10.2
doi:10.1016/j.mtbio.2025.102232
Luo, Yunbo; Wang, Yali; Su, Xiaohan; Li, Xue; Zeng, Jiao; Deng, Shishan; Deng, Wei; Xu, Jia; Hou, Lingmi
RCC1
发表日期：2025
文献求助 收藏

The crosstalk of breast cancer and ischemic heart disease

乳腺癌与缺血性心脏病的相互作用

期刊:Cell Death Discovery
影响因子:7
doi:10.1038/s41420-025-02428-6
Luo, Yunbo; Liu, Jun; Qu, Peng; Han, Shiqi; Li, Xue; Wang, Yali; Su, Xiaohan; Zeng, Jiao; Li, Jinsui; Deng, Shishan; Liang, Qi; Hou, Lingmi; Cheng, Panke
肿瘤
肿瘤免疫
心血管
乳腺癌
心脏病
发表日期：2025
文献求助 收藏

Application of Gene Editing Technology Based on Targeted Delivery Materials in TNBC

基于靶向递送材料的基因编辑技术在三阴性乳腺癌中的应用

期刊:ACS Omega
影响因子:4.3
doi:10.1021/acsomega.5c01294
Qu, Peng; Li, Xue; Liu, Jun; Su, Xiaohan; Han, Shiqi; Wang, Yali; Luo, Yunbo; Li, Jinsui; Ma, Cui; Deng, Shishan; Hou, Lingmi; Liang, Qi; Cheng, Panke
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

The risk of heart-specific death in breast cancer patients

乳腺癌患者发生心脏特异性死亡的风险

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-12648-6
Luo, Yunbo; Zhao, Long; Qu, Peng; Han, Shiqi; Wang, Yali; Li, Xue; Liu, Jun; Ma, Cui; Deng, Shishan; Liang, Qi; Hou, Lingmi; Cheng, Panke
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Global trends and research hotspots in autophagy and tumor drug resistance: a bibliometric analysis

自噬与肿瘤耐药性的全球趋势和研究热点：文献计量分析

期刊:Discover Oncology
影响因子:2.9
doi:10.1007/s12672-025-02379-5
Zhao, Long; Zeng, Jiao; Wen, Junfeng; Li, Zhaoyang; Xu, Jianguo; Wang, Jinxiang; Tang, Xiaoping; Hou, Lingmi
肿瘤
自噬
肿瘤免疫
发表日期：2025
文献求助 收藏

Case report: Microwave ablation is a safe and effective method for primary hyperparathyroidism in pregnancy

病例报告：微波消融术是治疗妊娠期原发性甲状旁腺功能亢进症的一种安全有效的方法。

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2024.1204696
Luo, Yunbo; Lv, Qi; Xu, Zhou; Fang, Jiang; Pu, Hongyu; Gao, Yanchun; Qian, Shuangqiang; Chen, Fei; Zhao, Xiaobo; Hou, Lingmi
发表日期：2024
文献求助 收藏

Development and validation of nomograms for predicting survival outcomes in patients with T1-2N1 breast cancer to identify those who could not benefit from postmastectomy radiotherapy

开发和验证用于预测T1-2N1期乳腺癌患者生存结果的列线图，以识别那些无法从乳房切除术后放疗中获益的患者。

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1112687
Pu, Hongyu; Luo, Yunbo; Zhang, Linxing; Li, Xin; Li, Fangwei; Chen, Jingtai; Qian, Shuangqiang; Tang, Yunhui; Zhao, Xiaobo; Hou, Lingmi; Gao, Yanchun
乳腺癌
肿瘤免疫
肿瘤
发表日期：2023
文献求助 收藏